IMAX Co. (NYSE:IMAX - Free Report) - Analysts at Zacks Research raised their Q1 2025 earnings estimates for IMAX in a note issued to investors on Tuesday, March 11th. Zacks Research analyst R. Department now forecasts that the company will earn $0.11 per share for the quarter, up from their prior forecast of $0.10. The consensus estimate for IMAX's current full-year earnings is $0.91 per share. Zacks Research also issued estimates for IMAX's Q4 2025 earnings at $0.33 EPS, FY2025 earnings at $0.73 EPS, Q1 2026 earnings at $0.18 EPS, FY2026 earnings at $0.94 EPS and FY2027 earnings at $1.13 EPS.
A number of other equities analysts also recently commented on IMAX. Benchmark reiterated a "buy" rating and issued a $30.00 target price on shares of IMAX in a report on Thursday, February 20th. JPMorgan Chase & Co. boosted their target price on shares of IMAX from $25.00 to $27.00 and gave the stock a "neutral" rating in a report on Friday, February 21st. Barrington Research boosted their target price on shares of IMAX from $30.00 to $32.00 and gave the stock an "outperform" rating in a report on Thursday, February 20th. Wedbush reiterated an "outperform" rating and issued a $32.00 target price on shares of IMAX in a report on Thursday, February 20th. Finally, Rosenblatt Securities boosted their target price on shares of IMAX from $28.00 to $35.00 and gave the stock a "buy" rating in a report on Thursday, February 20th. Two investment analysts have rated the stock with a hold rating, eight have given a buy rating and one has issued a strong buy rating to the company's stock. According to MarketBeat, the stock presently has an average rating of "Moderate Buy" and an average target price of $30.67.
Check Out Our Latest Research Report on IMAX
IMAX Stock Down 2.0 %
NYSE:IMAX traded down $0.50 during mid-day trading on Friday, reaching $24.36. The company's stock had a trading volume of 497,194 shares, compared to its average volume of 698,526. IMAX has a 1 year low of $14.94 and a 1 year high of $27.77. The stock has a fifty day moving average of $24.64 and a 200-day moving average of $23.53. The firm has a market capitalization of $1.29 billion, a PE ratio of 49.71, a price-to-earnings-growth ratio of 1.49 and a beta of 1.22.
IMAX (NYSE:IMAX - Get Free Report) last released its quarterly earnings data on Wednesday, February 19th. The company reported $0.17 earnings per share for the quarter, missing analysts' consensus estimates of $0.31 by ($0.14). IMAX had a return on equity of 8.60% and a net margin of 7.40%. The business had revenue of $92.67 million during the quarter, compared to analysts' expectations of $104.08 million.
Hedge Funds Weigh In On IMAX
Several hedge funds and other institutional investors have recently bought and sold shares of the business. Janney Montgomery Scott LLC increased its holdings in IMAX by 1.9% in the 4th quarter. Janney Montgomery Scott LLC now owns 29,176 shares of the company's stock worth $747,000 after buying an additional 533 shares during the period. Blue Trust Inc. boosted its position in IMAX by 138.5% in the 4th quarter. Blue Trust Inc. now owns 966 shares of the company's stock worth $25,000 after purchasing an additional 561 shares in the last quarter. MetLife Investment Management LLC boosted its position in IMAX by 3.4% in the 4th quarter. MetLife Investment Management LLC now owns 25,918 shares of the company's stock worth $664,000 after purchasing an additional 848 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in IMAX by 3.9% in the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 24,395 shares of the company's stock worth $625,000 after purchasing an additional 905 shares in the last quarter. Finally, US Bancorp DE boosted its position in IMAX by 23.4% in the 3rd quarter. US Bancorp DE now owns 7,656 shares of the company's stock worth $157,000 after purchasing an additional 1,452 shares in the last quarter. Institutional investors and hedge funds own 93.51% of the company's stock.
About IMAX
(
Get Free Report)
IMAX Corporation, together with its subsidiaries, operates as a technology platform for entertainment and events worldwide. The company operates in two segments, Content Solutions and Technology Products and Services. The company offers IMAX DMR, a proprietary technology that digitally remasters films and other content into IMAX formats for distribution to the IMAX network; IMAX Enhanced that provides end-to-end technology across streaming content and entertainment devices at home; and SSIMWAVE, an AI-driven video quality solutions for media and entertainment companies.
Recommended Stories
Before you consider IMAX, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and IMAX wasn't on the list.
While IMAX currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
